计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| B646419-2mg |
2mg |
期货 ![]() |
| |
| B646419-5mg |
5mg |
期货 ![]() |
| |
| B646419-10mg |
10mg |
期货 ![]() |
| |
| B646419-50mg |
50mg |
期货 ![]() |
| |
| B646419-100mg |
100mg |
期货 ![]() |
|
| 规格或纯度 | ≥99% |
|---|---|
| 英文名称 | BMS-983970 |
| 生化机理 | BMS-983970 是一种口服泛 Notch 抑制剂,用于治疗多种癌症。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
BMS-983970 is an oral pan- Notch inhibitor for the treatment of multiplecancers In Vivo BMS-983970 demonstrates anti-tumor activity in T-cell acute lymphoblastic leukemia (T-ALL) and solid tumor xenograft models . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:Notch |
| 纯度 | ≥99% |
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机酸及其衍生物 |
| 类(Class) | 羧酸及其衍生物 |
| 亚类(Subclass) | 氨基酸、肽和类似物 |
| 中间层级节点(Intermediate Tree Nodes) | 氨基酸及其衍生物 - α氨基酸及其衍生物 |
| 直接上位类(Direct Parent) | N-酰基-α氨基酸及其衍生物 |
| 其他上位类(Alternative Parents) | 1,4-苯二氮卓类药物 N-酰胺 苯及其取代衍生物 芳基氟化物 仲羧酸酰胺 伯羧酸酰胺 内酰胺类 酮亚胺 炔丙基型1,3-偶极有机化合物 氮杂环化合物 有机氟化物 有机氧化物 碳氢化合物衍生物 羰基化合物 烷基氟化物 |
| 分子骨架(Molecular Framework) | Aromatic heteropolycyclic compounds |
| 取代基(Substituents) | N-acyl-alpha amino acid or derivatives - Benzodiazepine - 1,4-benzodiazepine - Aryl fluoride - Aryl halide - Monocyclic benzene moiety - Fatty acyl - Fatty amide - Benzenoid - N-acyl-amine - Carboxamide group - Ketimine - Lactam - Secondary carboxylic acid amide - Primary carboxylic acid amide - Azacycle - Organoheterocyclic compound - Organic 1,3-dipolar compound - Propargyl-type 1,3-dipolar organic compound - Organic nitrogen compound - Imine - Alkyl halide - Alkyl fluoride - Carbonyl group - Hydrocarbon derivative - Organic oxide - Organic oxygen compound - Organooxygen compound - Organonitrogen compound - Organohalogen compound - Organofluoride - Aromatic heteropolycyclic compound |
| 描述(Description) | 该化合物属于有机化合物类别中的正酰基-α-氨基酸及其衍生物。这类化合物含有α-氨基酸(或其衍生物),其末端氮原子上连接有酰基。 |
| 外部描述符(External Descriptors) | 暂无 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | (2S,3R)-2-(cyclopropylmethyl)-N'-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide |
| INCHI | 1S/C26H26F4N4O3/c27-19-8-4-7-17-20(15-5-2-1-3-6-15)32-23(25(37)33-21(17)19)34-24(36)16(11-12-26(28,29)30)18(22(31)35)13-14-9-10-14/h1-8,14,16,18,23H,9-13H2,(H2,31,35)(H,33,37)(H,34,36)/t16-,18+,23-/m1/s1 |
| InChi Key | RANYIWAZSQWERN-WLENULPWSA-N |
| Smiles | C1CC1CC(C(CCC(F)(F)F)C(=O)NC2C(=O)NC3=C(C=CC=C3F)C(=N2)C4=CC=CC=C4)C(=O)N |
| Isomeric SMILES | C1CC1C[C@@H]([C@@H](CCC(F)(F)F)C(=O)N[C@@H]2C(=O)NC3=C(C=CC=C3F)C(=N2)C4=CC=CC=C4)C(=O)N |
| PubChem CID | 73388374 |
| 分子量 | 518.50 |
| 溶解性 | DMSO : ≥ 50 mg/mL (96.43 mM) |
|---|---|
| 分子量 | 518.500 g/mol |
| XLogP3 | 4.100 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 9 |
| 精确质量Exact Mass | 518.194 Da |
| 单同位素质量Monoisotopic Mass | 518.194 Da |
| 拓扑极表面积Topological Polar Surface Area | 114.000 Ų |
| 重原子数Heavy Atom Count | 37 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 886.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 3 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |